B · Normal
[Onlicon: Signed a Comprehensive Cooperation Agreement on Innovative Drugs and Delivery Systems] On November 9th, Onlican (002940.SZ) announced that the company signed a "Comprehensive Cooperation Agreement on Innovative Drugs and Delivery Systems" with Suzhou Ruizhijie and MicroX to cooperate on three innovative drug pipelines. The total preclinical R&D budget is expected to be 89.5 million yuan. It is expected that the new R&D investment in the PCC phase this year will be approximately 20.5 million yuan.
A-share announcement express 🕐 2026-11-09 18:32
#A-share announcement express
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Baiyunshan: Subsidiary Guangzhou Pharmaceutical plans to publicly list to intro 11-09 19:19 [TigerPharm: Plans to participate in the privatization of subsidiary Frontage Ho 11-09 19:18 [Maiwei Shares: The concerted action agreement expires and the actual controller 11-09 19:15 [Valin Steel: The subsidiary plans to invest 3.147 billion yuan in the construct 11-09 19:10 [Han's CNC: Plans to repurchase the company's A shares for 200 million to 300 mi 11-09 19:10 [Hongda Electronics: Plans to raise no more than 1 billion yuan in additional ca 11-09 19:10

Comments

0/500
Captcha (click to refresh)
No comments yet